Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Boston Scientific Co. stock logo
BSX
Boston Scientific
$73.13
-0.2%
$67.82
$48.35
$74.39
$107.29B0.786.59 million shs8.79 million shs
The China Fund, Inc. stock logo
CHN
The China Fund
$10.35
+2.0%
$9.92
$9.00
$12.50
N/AN/A26,904 shs24,506 shs
Liberty Gold Corp. stock logo
LGD
Liberty Gold
C$0.36
+2.9%
C$0.29
C$0.23
C$0.57
C$123.44M1.35452,227 shs255,954 shs
Ormat Technologies, Inc. stock logo
ORA
Ormat Technologies
$63.10
-1.1%
$64.96
$58.73
$88.26
$3.81B0.48480,314 shs686,341 shs
PAF
Invesco FTSE RAFI Asia Pac ex-Jpn ETF
$53.20
$0.00
$44.11
$60.50
$21.28MN/A3,929 shs5,990 shs
10 Best Stocks to Own in 2024 Cover

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Boston Scientific Co. stock logo
BSX
Boston Scientific
+0.53%+8.72%+7.89%+19.91%+43.44%
The China Fund, Inc. stock logo
CHN
The China Fund
+0.25%+3.26%+1.70%+5.51%-12.12%
Liberty Gold Corp. stock logo
LGD
Liberty Gold
+4.48%+2.94%+25.00%+32.08%-33.96%
Ormat Technologies, Inc. stock logo
ORA
Ormat Technologies
-1.88%+1.32%-2.28%-2.07%-25.43%
PAF
Invesco FTSE RAFI Asia Pac ex-Jpn ETF
0.00%0.00%0.00%0.00%+0.00%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Boston Scientific Co. stock logo
BSX
Boston Scientific
4.3897 of 5 stars
2.53.00.04.22.62.52.5
The China Fund, Inc. stock logo
CHN
The China Fund
N/AN/AN/AN/AN/AN/AN/AN/A
Liberty Gold Corp. stock logo
LGD
Liberty Gold
1.2454 of 5 stars
3.50.00.00.03.40.00.0
Ormat Technologies, Inc. stock logo
ORA
Ormat Technologies
4.8147 of 5 stars
3.34.01.74.52.42.51.9
PAF
Invesco FTSE RAFI Asia Pac ex-Jpn ETF
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Boston Scientific Co. stock logo
BSX
Boston Scientific
2.95
Moderate Buy$75.092.68% Upside
The China Fund, Inc. stock logo
CHN
The China Fund
N/AN/AN/AN/A
Liberty Gold Corp. stock logo
LGD
Liberty Gold
3.00
BuyC$1.60344.44% Upside
Ormat Technologies, Inc. stock logo
ORA
Ormat Technologies
2.50
Moderate Buy$81.0028.37% Upside
PAF
Invesco FTSE RAFI Asia Pac ex-Jpn ETF
0.00
N/AN/AN/A

Current Analyst Ratings

Latest PAF, ORA, CHN, BSX, and LGD Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/26/2024
Boston Scientific Co. stock logo
BSX
Boston Scientific
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$70.00 ➝ $78.00
4/25/2024
Boston Scientific Co. stock logo
BSX
Boston Scientific
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$79.00 ➝ $85.00
4/25/2024
Boston Scientific Co. stock logo
BSX
Boston Scientific
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$72.00 ➝ $82.00
4/25/2024
Boston Scientific Co. stock logo
BSX
Boston Scientific
Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetHold ➝ Hold$63.00 ➝ $73.00
4/25/2024
Boston Scientific Co. stock logo
BSX
Boston Scientific
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$78.00 ➝ $82.00
4/25/2024
Boston Scientific Co. stock logo
BSX
Boston Scientific
Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetStrong-Buy ➝ Strong-Buy$73.00 ➝ $85.00
4/25/2024
Boston Scientific Co. stock logo
BSX
Boston Scientific
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$74.00 ➝ $90.00
4/25/2024
Boston Scientific Co. stock logo
BSX
Boston Scientific
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$80.00 ➝ $85.00
4/25/2024
Boston Scientific Co. stock logo
BSX
Boston Scientific
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$72.00 ➝ $78.00
4/25/2024
Boston Scientific Co. stock logo
BSX
Boston Scientific
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$72.00 ➝ $82.00
4/23/2024
Liberty Gold Corp. stock logo
LGD
Liberty Gold
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetC$2.00 ➝ C$2.50
(Data available from 4/26/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Boston Scientific Co. stock logo
BSX
Boston Scientific
$14.24B7.53$2.91 per share25.11$13.33 per share5.49
The China Fund, Inc. stock logo
CHN
The China Fund
$11.22MN/AN/AN/AN/AN/A
Liberty Gold Corp. stock logo
LGD
Liberty Gold
N/AN/AC$0.06 per share6.34C$0.09 per shareN/A
Ormat Technologies, Inc. stock logo
ORA
Ormat Technologies
$829.42M4.60$5.58 per share11.31$40.44 per share1.56
PAF
Invesco FTSE RAFI Asia Pac ex-Jpn ETF
N/AN/AN/AN/AN/AN/A

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Boston Scientific Co. stock logo
BSX
Boston Scientific
$1.59B$1.1961.4528.792.4812.06%16.63%9.24%7/25/2024 (Estimated)
The China Fund, Inc. stock logo
CHN
The China Fund
N/AN/A0.00N/AN/AN/AN/AN/A
Liberty Gold Corp. stock logo
LGD
Liberty Gold
-C$22.11M-C$0.10N/AN/AN/A-53.91%-29.83%5/9/2024 (Estimated)
Ormat Technologies, Inc. stock logo
ORA
Ormat Technologies
$124.40M$2.0930.1926.973.0415.00%5.09%2.41%5/8/2024 (Confirmed)
PAF
Invesco FTSE RAFI Asia Pac ex-Jpn ETF
N/AN/A0.00N/AN/AN/AN/AN/A

Latest PAF, ORA, CHN, BSX, and LGD Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/8/2024N/A
Ormat Technologies, Inc. stock logo
ORA
Ormat Technologies
$0.68N/A-$0.68N/AN/AN/A  
2/21/2024Q4 2023
Ormat Technologies, Inc. stock logo
ORA
Ormat Technologies
$0.60$0.67+$0.07$0.75$239.71 million$241.30 million    
1/31/2024Q4 23
Boston Scientific Co. stock logo
BSX
Boston Scientific
$0.51$0.55+$0.04$0.76$3.59 billion$3.73 billion    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Boston Scientific Co. stock logo
BSX
Boston Scientific
N/AN/AN/AN/AN/A
The China Fund, Inc. stock logo
CHN
The China Fund
$0.010.10%-50.25%N/AN/A
Liberty Gold Corp. stock logo
LGD
Liberty Gold
N/AN/AN/AN/AN/A
Ormat Technologies, Inc. stock logo
ORA
Ormat Technologies
$0.480.76%+2.94%22.97%N/A
PAF
Invesco FTSE RAFI Asia Pac ex-Jpn ETF
$2.113.97%N/AN/AN/A

Latest PAF, ORA, CHN, BSX, and LGD Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/21/2024
Ormat Technologies, Inc. stock logo
ORA
Ormat Technologies
Quarterly$0.120.75%3/5/20243/6/20243/20/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Boston Scientific Co. stock logo
BSX
Boston Scientific
0.44
1.32
0.82
The China Fund, Inc. stock logo
CHN
The China Fund
N/AN/AN/A
Liberty Gold Corp. stock logo
LGD
Liberty Gold
0.56
5.21
8.13
Ormat Technologies, Inc. stock logo
ORA
Ormat Technologies
0.64
1.20
1.12
PAF
Invesco FTSE RAFI Asia Pac ex-Jpn ETF
N/AN/AN/A

Ownership

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Boston Scientific Co. stock logo
BSX
Boston Scientific
48,0001.47 billion1.46 billionOptionable
The China Fund, Inc. stock logo
CHN
The China Fund
N/AN/AN/ANot Optionable
Liberty Gold Corp. stock logo
LGD
Liberty Gold
13342.90 millionN/ANot Optionable
Ormat Technologies, Inc. stock logo
ORA
Ormat Technologies
1,57660.40 million59.80 millionOptionable
PAF
Invesco FTSE RAFI Asia Pac ex-Jpn ETF
N/A400,000N/ANot Optionable

PAF, ORA, CHN, BSX, and LGD Headlines

No headlines for this company have been tracked by MarketBeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Boston Scientific logo

Boston Scientific

NYSE:BSX
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes; devices to treat urological conditions, including ureteral stents, catheters, baskets, guidewires, sheaths, balloons, single-use digital flexible ureteroscopes, holmium laser systems, artificial urinary sphincter, laser system, fiber, and hydrogel systems; and devices to treat neurological movement disorders and manage chronic pain, such as spinal cord stimulator system, proprietary programming software, radiofrequency generator, indirect decompression systems, practice optimization tools, and deep brain stimulation system. It also provides technologies for diagnosing and treating coronary artery disease and aortic valve conditions; WATCHMAN FLX, a Left Atrial Appendage Closure Device; and implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities, such as cardioverter and cardiac resynchronization therapy defibrillators, MRI S-ICD systems, cardiac resynchronization therapy pacemakers, quadripolar LV leads, ICD leads, pacing leads, remote patient management systems, insertable cardiac monitor systems, and remote cardiac monitoring systems. In addition, the company offers diagnosis and treatment of rate and rhythm disorders of the heart; peripheral arterial and venous diseases; and products to diagnose, treat and ease forms of cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.
The China Fund logo

The China Fund

NYSE:CHN
The China Fund, Inc. is a closed ended equity mutual fund launched and managed by Allianz Global Investors U.S. LLC. It invests in the public equity markets of China that includes the People's Republic of China, Hong Kong, and Taiwan. The fund invests in stocks of companies operating across diversified sectors. It employs a combination of fundamental analysis with bottom-up approach and quantitative analysis to create its portfolio. The fund seeks to benchmarks the performance of its portfolio against the MSCI Golden Dragon Index. The China Fund, Inc. was formed on April 28, 1992 and is domiciled in the United States.
Liberty Gold logo

Liberty Gold

TSE:LGD
Liberty Gold Corp. engages in the acquisition, exploration, and development of mineral properties primarily in the United States and Türkiye. The company primarily explores for gold, as well as silver, lead, zinc, copper, and other precious and base metals. It holds interest in the Black Pine project located in Cassia County, southern Idaho; the Goldstrike project located in Washington County, southwest Utah; and the TV Tower gold-silver-copper property located in northwestern Türkiye. The company was formerly known as Pilot Gold Inc. and changed its name to Liberty Gold Corp. in May 2017. Liberty Gold Corp. was incorporated in 2010 and is based in Vancouver, Canada.
Ormat Technologies logo

Ormat Technologies

NYSE:ORA
Ormat Technologies, Inc. engages in the geothermal and recovered energy power business in the United States, Indonesia, Kenya, Turkey, Chile, Guatemala, Guadeloupe, New Zealand, Honduras, and internationally. It operates in three segments: Electricity, Product, and Energy Storage. The Electricity segment develops, builds, owns, and operates geothermal, solar photovoltaic, and recovered energy-based power plants; and sells electricity. The Product segment designs, manufactures, and sells equipment for geothermal and recovered energy-based electricity generation; and provides services relating to the engineering, procurement, construction, operation, and maintenance of geothermal and recovered energy-based power plants. This segment serves contractors; and owners and operators of interstate natural gas pipelines, gas processing plants, and cement plants, as well as companies in other energy-intensive industrial processes. The Energy Storage segment offers battery energy storage systems and related services. Ormat Technologies, Inc. was founded in 1965 and is headquartered in Reno, Nevada.

Invesco FTSE RAFI Asia Pac ex-Jpn ETF

NYSEARCA:PAF
PowerShares FTSE RAFI Asia Pacific ex-Japan Portfolio (the Fund) is based on the FTSE RAFI Developed Asia Pacific ex Japan Index (Index). The Fund will normally invest at least 90% of its total assets in securities that comprise the Index and American Depositary Receipts (ADRs) based on the securities in the Index. The Index is designed to track the performance of the largest equities of companies domiciled in the Asia Pacific region (excluding Japan), selected based on the four fundamental measures of firm size: book value, income, sales and dividends. The 1000 equities with the highest fundamental strength are weighted according to their fundamental scores. The fundamentally weighted portfolio is rebalanced and reconstituted annually. The Fund invests in consumer discretionary, consumer staples, energy, financials, health care, industrials, information technology and telecommunicaiton services sectors. The Fund's investment advisor is Invesco PowerShares Capital Management LLC.